Lyoc – medication that doesn’t need water!

[28 November 2007 - 11h47]

By now you’ll almost certainly have heard of Lyoc – it’s an oral form of medication that dissolves instantly in the mouth on contact with saliva. No water needed! This galenical preparation is highly valued in the developed world for its ease of use and is also particularly well suited to use in developing countries faced with sanitation problems.

In Africa and the Middle East, for example. “Wherever you are, if you have a product available in Lyoc form, you don’t need water or anything else in order to swallow it”, points out Alain Aragues, president of Cephalon Europe who developed this Lyoc formulation. This means that it offers valuable flexibility of use and many other advantages.

First of all, it makes taking medication safer as it is absorbed without water. This leads to a reduction in the risk of the diarrhoeic diseases that cause millions of deaths in Africa every year. Another plus for Lyoc is the improved effectiveness of the medication. “It’s what we call an ‘attack product’ as it increases the availability” of the active principle, continues Aragues. This means that with Lyoc, lower doses can be taken and the same level of effectiveness achieved.

And as it is easy to administer, there is better observance of treatment. This is particularly true of patients who have difficulties swallowing, such as the elderly ... and also the very young.

In Europe, Africa and the Middle East more than 20 medicines now benefit from Lyoc technology, including pain-relief, drugs to combat cancer and osteoarthritis, and antibiotics. And world demand is continuing to grow. Cephalon therefore recently opened a new production and packaging unit in Nevers, France. This will turn out more than 33 million Lyoc-form drugs every year.

Source : Laboratoire Cephalon

>> Cet article est aussi disponible en français

>> Cet article est aussi disponible en arabe

© 1996-2012 Destination Santé SAS - All Rights Reserved. No information contained on this server can be reproduced or retransmitted without prior written consent of Destination Santé. Offenders will be prosecuted in consideration of articles L 122-4 and L 335-3 of the Code of Intellectual Property, allowing up to two years' imprisonment and a 150,000 euros fine.